Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

HMA/Ventoclax vs. 3+7/Standard Induction - Should All Older and Younger AML Patients with Adverse Biology Routinely Receive It?

41 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login